CN111094588A - 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 - Google Patents
一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 Download PDFInfo
- Publication number
- CN111094588A CN111094588A CN201880046701.5A CN201880046701A CN111094588A CN 111094588 A CN111094588 A CN 111094588A CN 201880046701 A CN201880046701 A CN 201880046701A CN 111094588 A CN111094588 A CN 111094588A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- target
- acid molecule
- cas protein
- stranded dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 109
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 101
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 101
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 101
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 86
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 77
- 238000001814 protein method Methods 0.000 title description 2
- 238000006243 chemical reaction Methods 0.000 claims abstract description 132
- 108700004991 Cas12a Proteins 0.000 claims abstract description 130
- 108020005004 Guide RNA Proteins 0.000 claims abstract description 51
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims abstract description 38
- 239000002853 nucleic acid probe Substances 0.000 claims abstract description 38
- 108020004414 DNA Proteins 0.000 claims description 229
- 102000053602 DNA Human genes 0.000 claims description 142
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 122
- 238000000034 method Methods 0.000 claims description 88
- 238000003776 cleavage reaction Methods 0.000 claims description 80
- 230000007017 scission Effects 0.000 claims description 60
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 57
- 230000003321 amplification Effects 0.000 claims description 56
- 230000000694 effects Effects 0.000 claims description 50
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 49
- 239000000523 sample Substances 0.000 claims description 43
- 238000013518 transcription Methods 0.000 claims description 36
- 230000035897 transcription Effects 0.000 claims description 36
- 239000000872 buffer Substances 0.000 claims description 33
- 238000012360 testing method Methods 0.000 claims description 29
- 230000007018 DNA scission Effects 0.000 claims description 27
- 238000001917 fluorescence detection Methods 0.000 claims description 26
- 230000035772 mutation Effects 0.000 claims description 26
- 101000860092 Francisella tularensis subsp. novicida (strain U112) CRISPR-associated endonuclease Cas12a Proteins 0.000 claims description 22
- 239000007850 fluorescent dye Substances 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 18
- 238000012408 PCR amplification Methods 0.000 claims description 16
- 230000000295 complement effect Effects 0.000 claims description 12
- 230000004544 DNA amplification Effects 0.000 claims description 8
- 238000005520 cutting process Methods 0.000 claims description 8
- 101100385358 Alicyclobacillus acidoterrestris (strain ATCC 49025 / DSM 3922 / CIP 106132 / NCIMB 13137 / GD3B) cas12b gene Proteins 0.000 claims description 5
- 230000027455 binding Effects 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 244000000010 microbial pathogen Species 0.000 claims description 3
- 101000794020 Homo sapiens Bromodomain-containing protein 8 Proteins 0.000 claims description 2
- 101001006782 Homo sapiens Kinesin-associated protein 3 Proteins 0.000 claims description 2
- 101000615355 Homo sapiens Small acidic protein Proteins 0.000 claims description 2
- 102100027930 Kinesin-associated protein 3 Human genes 0.000 claims description 2
- WGKGADVPRVLHHZ-ZHRMCQFGSA-N N-[(1R,2R,3S)-2-hydroxy-3-phenoxazin-10-ylcyclohexyl]-4-(trifluoromethoxy)benzenesulfonamide Chemical compound O[C@H]1[C@@H](CCC[C@@H]1N1C2=CC=CC=C2OC2=C1C=CC=C2)NS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1 WGKGADVPRVLHHZ-ZHRMCQFGSA-N 0.000 claims description 2
- 238000007834 ligase chain reaction Methods 0.000 claims description 2
- 238000005096 rolling process Methods 0.000 claims description 2
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 claims 7
- 239000002184 metal Substances 0.000 claims 1
- 102100039087 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Human genes 0.000 description 37
- 229920002401 polyacrylamide Polymers 0.000 description 37
- 108091034117 Oligonucleotide Proteins 0.000 description 36
- 241000588724 Escherichia coli Species 0.000 description 25
- 239000000047 product Substances 0.000 description 25
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 23
- 238000000137 annealing Methods 0.000 description 20
- 101150013736 gyrB gene Proteins 0.000 description 18
- 230000009467 reduction Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000001816 cooling Methods 0.000 description 17
- 238000004925 denaturation Methods 0.000 description 17
- 230000036425 denaturation Effects 0.000 description 17
- 230000004044 response Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 230000005284 excitation Effects 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 13
- 244000005700 microbiome Species 0.000 description 12
- 238000000746 purification Methods 0.000 description 12
- 239000003161 ribonuclease inhibitor Substances 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 108091033409 CRISPR Proteins 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 101150012629 parE gene Proteins 0.000 description 9
- 201000005569 Gout Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 230000007613 environmental effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 5
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 5
- 108010042407 Endonucleases Proteins 0.000 description 5
- 102000004533 Endonucleases Human genes 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000008223 sterile water Substances 0.000 description 5
- 238000010354 CRISPR gene editing Methods 0.000 description 4
- 239000003298 DNA probe Substances 0.000 description 4
- 101150080074 TP53 gene Proteins 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108700025694 p53 Genes Proteins 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 241001147780 Alicyclobacillus Species 0.000 description 3
- 241000193412 Alicyclobacillus acidoterrestris Species 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108010040467 CRISPR-Associated Proteins Proteins 0.000 description 2
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 101000883798 Homo sapiens Probable ATP-dependent RNA helicase DDX53 Proteins 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 102100038236 Probable ATP-dependent RNA helicase DDX53 Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102100026260 Titin Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000007481 next generation sequencing Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 241001588186 Acidaminococcus sp. BV3L6 Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001063273 Alicyclobacillus acidiphilus Species 0.000 description 1
- 241000850379 Alicyclobacillus kakegawensis Species 0.000 description 1
- 241000182988 Assa Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000380736 Bacteroidales bacterium KA00251 Species 0.000 description 1
- 241001232588 Bacteroidetes oral taxon 274 str. F0058 Species 0.000 description 1
- 108091079001 CRISPR RNA Proteins 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 102220613830 Casein kinase II subunit alpha 3_D1255A_mutation Human genes 0.000 description 1
- 102220613440 Casein kinase II subunit alpha 3_D917A_mutation Human genes 0.000 description 1
- 102220613443 Casein kinase II subunit alpha 3_E1006A_mutation Human genes 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000589602 Francisella tularensis Species 0.000 description 1
- 241000721561 Helcococcus kunzii ATCC 51366 Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000931098 Homo sapiens DNA (cytosine-5)-methyltransferase 1 Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 241000448225 Lachnospiraceae bacterium MC2017 Species 0.000 description 1
- 241000689677 Lachnospiraceae bacterium NC2008 Species 0.000 description 1
- 241000689670 Lachnospiraceae bacterium ND2006 Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241001365624 Oribacterium sp. NK2B42 Species 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 241000408643 Thiomicrospira sp. XS5 Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- 208000020329 Zika virus infectious disease Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000000007 bacterial human pathogen Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- -1 crRNA Proteins 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 229940118764 francisella tularensis Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- NLJUOWMZPAVXHU-UHFFFAOYSA-N prop-2-enamide;urea Chemical compound NC(N)=O.NC(=O)C=C NLJUOWMZPAVXHU-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- NMEHNETUFHBYEG-IHKSMFQHSA-N tttn Chemical group C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 NMEHNETUFHBYEG-IHKSMFQHSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供了一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒,靶标核酸分子的检测方法包括向含有待检靶标核酸分子的反应体系中加入向导RNA、Cas12a、核酸探针,反应完成后对其进行检测。
Description
PCT国内申请,说明书已公开。
Claims (21)
- PCT国内申请,权利要求书已公开。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410308071.1A CN118207297A (zh) | 2017-07-14 | 2018-04-12 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710573752.0A CN107488710B (zh) | 2017-07-14 | 2017-07-14 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN2017105737520 | 2017-07-14 | ||
PCT/CN2018/082769 WO2019011022A1 (zh) | 2017-07-14 | 2018-04-12 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410308071.1A Division CN118207297A (zh) | 2017-07-14 | 2018-04-12 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111094588A true CN111094588A (zh) | 2020-05-01 |
CN111094588B CN111094588B (zh) | 2024-04-05 |
Family
ID=60643750
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710573752.0A Active CN107488710B (zh) | 2017-07-14 | 2017-07-14 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN202011092324.4A Pending CN112501254A (zh) | 2017-07-14 | 2017-07-14 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN202410308071.1A Pending CN118207297A (zh) | 2017-07-14 | 2018-04-12 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN201880046701.5A Active CN111094588B (zh) | 2017-07-14 | 2018-04-12 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710573752.0A Active CN107488710B (zh) | 2017-07-14 | 2017-07-14 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN202011092324.4A Pending CN112501254A (zh) | 2017-07-14 | 2017-07-14 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN202410308071.1A Pending CN118207297A (zh) | 2017-07-14 | 2018-04-12 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20230002811A1 (zh) |
EP (1) | EP3653722A4 (zh) |
JP (2) | JP2020530779A (zh) |
KR (1) | KR20200035956A (zh) |
CN (4) | CN107488710B (zh) |
AU (1) | AU2018299445B2 (zh) |
BR (1) | BR112020000809A2 (zh) |
CA (1) | CA3069788A1 (zh) |
EA (1) | EA202090290A1 (zh) |
IL (1) | IL272005A (zh) |
MA (1) | MA49579A (zh) |
MX (1) | MX2020000481A (zh) |
NZ (1) | NZ760987A (zh) |
PH (1) | PH12020500103A1 (zh) |
SG (1) | SG11202000336RA (zh) |
WO (1) | WO2019011022A1 (zh) |
ZA (1) | ZA202000682B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110551800A (zh) * | 2018-06-03 | 2019-12-10 | 上海吐露港生物科技有限公司 | 一种耐高温Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN111733216A (zh) * | 2020-06-22 | 2020-10-02 | 山东舜丰生物科技有限公司 | 一种提高目标核酸检测效率的方法 |
CN112301162A (zh) * | 2020-10-22 | 2021-02-02 | 清华-伯克利深圳学院筹备办公室 | 同时检测dna病毒和rna病毒的病毒核酸检测方法 |
CN112795624A (zh) * | 2020-07-17 | 2021-05-14 | 山东舜丰生物科技有限公司 | 利用含有无碱基间隔物的核酸检测器检测靶核酸的方法 |
CN113061650A (zh) * | 2021-02-19 | 2021-07-02 | 中国科学院深圳先进技术研究院 | 一种病原体核酸的即时检测***及方法 |
CN113293198A (zh) * | 2020-09-18 | 2021-08-24 | 山东舜丰生物科技有限公司 | 基于crispr技术进行靶核酸多重检测的方法 |
CN113355397A (zh) * | 2021-06-24 | 2021-09-07 | 深圳市第二人民医院(深圳市转化医学研究院) | 场效应晶体管芯片、检测核酸的试剂盒和核酸含量的检测方法 |
CN114807316A (zh) * | 2022-03-11 | 2022-07-29 | 北京科技大学 | 一种无核酸扩增可视化的rna定量检测方法 |
WO2023087290A1 (en) * | 2021-11-20 | 2023-05-25 | Agricultural Genomics Institute At Shenzhen, Chinese Academy Of Agricultural Sciences | Methods for nucleic acid detection |
CN116179511A (zh) * | 2023-03-10 | 2023-05-30 | 之江实验室 | Cpf1蛋白在制备用于核酸检测的试剂盒中的应用 |
CN117821630A (zh) * | 2024-02-20 | 2024-04-05 | 江苏省家禽科学研究所 | 用于检测肠炎沙门氏菌的核酸检测试剂盒及方法 |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11584955B2 (en) | 2017-07-14 | 2023-02-21 | Shanghai Tolo Biotechnology Company Limited | Application of Cas protein, method for detecting target nucleic acid molecule and kit |
CN107488710B (zh) * | 2017-07-14 | 2020-09-22 | 上海吐露港生物科技有限公司 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
US10253365B1 (en) | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
CN108220400A (zh) * | 2018-01-02 | 2018-06-29 | 武汉启丰生物技术有限公司 | 一种基于CRISPR-Cas10核酸蛋白复合物的快捷核酸检测定量法 |
US11851701B2 (en) | 2018-03-15 | 2023-12-26 | Eiken Kagaku Kabushiki Kaisha | Oligonucleotide probe for detecting single nucleotide polymorphisms, and method for determining cis-trans configuration |
CN108796036B (zh) * | 2018-04-03 | 2021-11-19 | 交弘生物科技(上海)有限公司 | 基于原核Argonaute蛋白的核酸检测方法及其应用 |
CN108588182A (zh) * | 2018-04-13 | 2018-09-28 | 中国科学院深圳先进技术研究院 | 基于crispr-链取代的等温扩增及检测技术 |
CN112941155B (zh) * | 2018-05-14 | 2023-07-14 | 北京艾克伦医疗科技有限公司 | 具有茎环结构的dna引物对及其应用 |
SG11202012785VA (en) * | 2018-06-26 | 2021-01-28 | Broad Inst Inc | Crispr double nickase based amplification compositions, systems, and methods |
EP3830301B1 (en) | 2018-08-01 | 2024-05-22 | Mammoth Biosciences, Inc. | Programmable nuclease compositions and methods of use thereof |
WO2020030984A2 (en) * | 2018-08-09 | 2020-02-13 | G+Flas Life Sciences | Compositions and methods for genome engineering with cas12a proteins |
US20210317527A1 (en) * | 2018-08-27 | 2021-10-14 | The Regents Of The University Of California | Reporter nucleic acids for type v crispr-mediated detection |
CN109055499B (zh) * | 2018-08-30 | 2021-01-19 | 杭州杰毅生物技术有限公司 | 基于CRISPR-Cas的等温核酸检测方法及试剂盒 |
US20210381038A1 (en) * | 2018-09-20 | 2021-12-09 | Institute Of Zoology, Chinese Academy Of Sciences | Method for detecting nucleic acid |
CN111117984A (zh) * | 2018-11-01 | 2020-05-08 | 浙江大学 | 可视化特异检测核酸目标的crispr体系及方法和装置 |
CN111154913B (zh) * | 2018-11-08 | 2023-04-18 | 中山大学 | 用于EB病毒DNA检测的引物和crRNA及其应用 |
CN109251963B (zh) * | 2018-11-12 | 2022-11-18 | 复旦大学 | 恒温检测细胞培养液中支原体污染的方法及试剂盒 |
CN109666662A (zh) * | 2018-12-12 | 2019-04-23 | 广州普世利华科技有限公司 | 新型ScCas12a在核酸检测方面的应用 |
WO2020142754A2 (en) | 2019-01-04 | 2020-07-09 | Mammoth Biosciences, Inc. | Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection |
CN109628564B (zh) * | 2019-02-25 | 2022-02-01 | 北京市理化分析测试中心 | 一种用于检测snp多态性的引物组和利用引物组检测snp多态性的方法 |
CN109929949B (zh) * | 2019-03-14 | 2019-12-31 | 广州医科大学附属肿瘤医院 | 基于CRISPR-Cas12a和G四链体-血红素的EBV的检测方法及应用 |
CN110117818A (zh) * | 2019-04-16 | 2019-08-13 | 天津大学 | 检测单基因突变的crispr高通量生物芯片 |
CN110029194A (zh) * | 2019-04-24 | 2019-07-19 | 安邦(厦门)生物科技有限公司 | 基于CRISPR-Cas基因编辑技术的连续荧光监测检测方法及装置 |
CN111855990B (zh) * | 2019-04-29 | 2023-06-27 | 华南师范大学 | 一种基于CRISPR/Cas***的通用比色核酸检测方法及试剂盒与应用 |
CN110195102A (zh) * | 2019-04-30 | 2019-09-03 | 广州普世利华科技有限公司 | 一种β地中海贫血基因分型方法 |
CN110257556B (zh) * | 2019-04-30 | 2023-04-18 | 广州普世利华科技有限公司 | 一种性传播疾病致病病原的核酸检测试剂盒 |
CN110157821B (zh) * | 2019-05-06 | 2020-08-28 | 浙江大学 | 一种用于人葡萄球菌检测的试剂盒 |
CN111944879B (zh) * | 2019-05-16 | 2024-05-14 | 华南师范大学 | 一种非疾病诊断目的的基于crispr技术的基因检测方法 |
CN110331219A (zh) * | 2019-06-24 | 2019-10-15 | 浙江大学 | 一种用于铜绿假单胞菌检测的试剂盒 |
CN110317890A (zh) * | 2019-06-24 | 2019-10-11 | 浙江大学 | 一种用于粪肠球菌检测的试剂盒 |
CN110241238B (zh) * | 2019-06-24 | 2020-03-03 | 浙江大学 | 一种用于化脓链球菌检测的试剂盒 |
CN110358848A (zh) * | 2019-06-24 | 2019-10-22 | 浙江大学 | 一种用于屎肠球菌检测的试剂盒 |
CN112301101A (zh) * | 2019-07-24 | 2021-02-02 | 上海吐露港生物科技有限公司 | Crispr多靶标检测方法及其试剂盒 |
CN112301102B (zh) * | 2019-07-31 | 2024-06-25 | 华南师范大学 | 一种高特异性的环介导等温扩增方法及其应用 |
CN110819652A (zh) * | 2019-08-21 | 2020-02-21 | 山东金城生物药业有限公司 | 一种谷氨酸棒杆菌同时基因敲除及基因表达抑制的双功能***及应用 |
CN110894557A (zh) * | 2019-09-20 | 2020-03-20 | 武汉大学 | 基于CRISPR方式检测非洲猪瘟病毒的crRNA及试剂盒 |
CN110551812B (zh) * | 2019-09-26 | 2020-08-18 | 暨南大学 | 一种诊断脊髓性肌萎缩症的CRISPR-Cas***及其应用 |
CN110982878B (zh) * | 2019-11-29 | 2023-06-13 | 华南师范大学 | CRISPR/Cas13a结合电化学发光***检测microRNA的方法与应用 |
CN111007240A (zh) * | 2019-12-02 | 2020-04-14 | 中国医学科学院北京协和医院 | 一种基于crispr技术的均相酶免疫检验***及其方法和应用 |
CN110878343B (zh) * | 2019-12-03 | 2023-04-07 | 国家卫生健康委科学技术研究所 | 一种用于遗传性耳聋致病基因SLC26A4突变快速检测的Cpf1试剂盒及其检测方法 |
CN116400066A (zh) * | 2019-12-11 | 2023-07-07 | 北京聚树生物科技有限公司 | 一种检测混合体系内目标分子浓度的方法及试剂盒 |
CN112941153B (zh) * | 2019-12-11 | 2022-09-09 | 清华大学 | 一种dna检测方法 |
CN110894530B (zh) * | 2019-12-25 | 2020-12-08 | 武汉博杰生物医学科技有限公司 | 结肠癌相关分子标志物基因突变的检测试剂盒与检测方法 |
CN111304294A (zh) * | 2020-01-17 | 2020-06-19 | 中国医学科学院北京协和医院 | Pcda囊泡结合crispr的快速检测***及其方法 |
BR112022014777A2 (pt) | 2020-01-27 | 2022-09-20 | Sherlock Biosciences Inc | Ensaios de detecção aprimorados |
WO2021155775A1 (zh) * | 2020-02-03 | 2021-08-12 | 苏州克睿基因生物科技有限公司 | 一种检测靶核酸的方法和试剂盒 |
CN111197098B (zh) * | 2020-02-20 | 2023-08-22 | 首都医科大学附属北京胸科医院 | 一种从痰液中检测结核分枝杆菌的方法 |
CN111455046A (zh) * | 2020-03-13 | 2020-07-28 | 深圳市罗湖区人民医院 | 一种adgrg6增强子突变的核酸检测方法及其试剂盒 |
CN111440793B (zh) * | 2020-03-20 | 2021-11-05 | 武汉博杰生物医学科技有限公司 | 一种新型冠状病毒核酸检测试剂盒 |
US11851702B2 (en) * | 2020-03-23 | 2023-12-26 | The Broad Institute, Inc. | Rapid diagnostics |
CN111560469A (zh) * | 2020-03-30 | 2020-08-21 | 广州和盛医疗科技有限公司 | 一组检测新冠病毒基因的引物及crispr序列组合及其应用 |
CN111363763B (zh) * | 2020-03-31 | 2023-03-14 | 海南大学 | 一种RNA激活Cas14a酶附带切割效应的方法 |
CN111257297B (zh) * | 2020-03-31 | 2023-06-16 | 海南大学 | 一种基于Cas14a酶的RNA检测方法 |
CN111549177A (zh) * | 2020-04-27 | 2020-08-18 | 广州再生医学与健康广东省实验室 | 用于检测SARS-CoV-2的gRNA及试剂盒 |
TW202219272A (zh) | 2020-06-12 | 2022-05-16 | 美商夏洛克生物科學公司 | SARS-CoV-2之偵測 |
CN111733287B (zh) * | 2020-06-22 | 2022-10-11 | 天津大学 | 检测发热伴血小板减少综合征病原体核酸的试剂盒 |
CN111662968A (zh) * | 2020-06-23 | 2020-09-15 | 南方科技大学 | 一种基于crispr的无pam序列dna的检测方法及其应用 |
CN111909987A (zh) * | 2020-07-31 | 2020-11-10 | 浙江科途医学科技有限公司 | 用于kif5b-ret融合基因检测的试剂组合物、试剂盒及检测*** |
CN113789365B (zh) * | 2020-08-28 | 2022-11-22 | 山东舜丰生物科技有限公司 | 基于crispr技术进行多重核酸检测的方法 |
CN112251494B (zh) * | 2020-10-09 | 2022-09-02 | 湖南大学 | 基于CRISPR-Cas自催化放大网络的核酸检测方法及其应用 |
WO2022080343A1 (ja) * | 2020-10-13 | 2022-04-21 | キヤノン株式会社 | 核酸検出装置および核酸の検出方法 |
CN112695073A (zh) * | 2020-12-30 | 2021-04-23 | 上海理工大学 | 一种CRISPR/Cas12a一步核酸检测方法 |
CN112831544B (zh) * | 2020-12-31 | 2024-06-14 | 华南农业大学 | 一种基于CRISPR/Cas12a***的生物检测方法和生物检测装置 |
CN115335536A (zh) * | 2021-01-08 | 2022-11-11 | 武汉大学 | 用于即时核酸检测的组合物和方法 |
EP4291678A1 (en) | 2021-02-09 | 2023-12-20 | Sherlock Biosciences, Inc. | Nucleic acid amplification using promoter primers |
CN113046477A (zh) * | 2021-02-26 | 2021-06-29 | 广州医科大学附属第一医院(广州呼吸中心) | 鉴定D614G突变位点的特异性crRNA、体系、试剂盒及应用 |
NO347409B1 (no) * | 2021-04-11 | 2023-10-23 | Glomsroed Mikkel Ante | Fremgangsmåte for påvisning av mikroorganismer eller genfeil |
CN114807431A (zh) * | 2021-04-15 | 2022-07-29 | 华中农业大学 | 一种改进的基于crispr***介导的核酸可视化检测技术及其应用 |
CN113324956B (zh) * | 2021-04-22 | 2023-06-09 | 上海市肿瘤研究所 | 一种基于crispr技术与框架核酸耦合的模块化检测平台、构建方法及其应用 |
CN112852980B (zh) * | 2021-04-23 | 2021-11-26 | 上海海关动植物与食品检验检疫技术中心 | 基于crispr荧光法检测大西洋鲑核酸的检测方法及其检测试剂盒 |
CN113444817A (zh) * | 2021-05-12 | 2021-09-28 | 中国人民解放军军事科学院军事医学研究院 | 一种基于CRISPR-Cas12a***的炭疽芽胞杆菌检测方法 |
CN113403424B (zh) * | 2021-05-28 | 2024-01-09 | 华南理工大学 | 基于CRISPR/Cas12a技术快速检测新冠病毒和突变株的方法及试剂盒 |
CN113337489A (zh) * | 2021-06-07 | 2021-09-03 | 广州美格生物科技有限公司 | 一种新型嵌合体TsCas12a蛋白及制备技术 |
CN113373264B (zh) * | 2021-06-10 | 2022-04-12 | 安徽医科大学 | 一种基于CRISPR/Cas***的新型冠状病毒双靶标快速检测方法及试剂盒 |
CN113980957A (zh) * | 2021-07-02 | 2022-01-28 | 苏州***医学研究所 | 基于CRISPR/Cas12a的单链DNA探针及检测目标核酸的方法 |
CN113388691B (zh) * | 2021-07-23 | 2022-08-30 | 中国疾病预防控制中心传染病预防控制所 | 一种基于PCR扩增和CRISPR-Cas12a的核酸检测方法及应用 |
CN113686934A (zh) * | 2021-08-13 | 2021-11-23 | 广东海洋大学 | 一种CRISPR/Cas12a-RCA电化学传感器检测体系及其应用 |
CN113999921B (zh) * | 2021-11-23 | 2023-06-27 | 中国医学科学院输血研究所 | 快速可视化检测福氏志贺氏菌的方法和试剂盒 |
CN114134218B (zh) * | 2021-12-02 | 2022-10-28 | 中国疾病预防控制中心传染病预防控制所 | 一种基于CRISPR-Cas12a的荧光检测方法 |
CN114292843B (zh) * | 2021-12-03 | 2023-07-21 | 中国科学院精密测量科学与技术创新研究院 | 一种基因***的CRISPR/Cas12a检测体系及其应用 |
CN114592043A (zh) * | 2022-03-23 | 2022-06-07 | 北京盛因生物科技有限公司 | 一种等温核酸检测酶组合物、试剂盒及其用途和检测方法 |
CN114634972B (zh) * | 2022-05-19 | 2022-08-26 | 舜丰生物科技(海南)有限公司 | 利用Cas酶进行核酸检测的方法 |
WO2024006552A1 (en) | 2022-07-01 | 2024-01-04 | Sherlock Biosciences, Inc. | Ambient temperature nucleic acid amplification and detection |
CN116240200A (zh) * | 2022-07-01 | 2023-06-09 | 中国科学院基础医学与肿瘤研究所(筹) | 一种基于可编程核酸酶的超灵敏目标核酸富集检测方法 |
CN115838831A (zh) * | 2022-08-29 | 2023-03-24 | 深圳市海微生物科技有限公司 | FnCas12a突变体在核酸检测中的应用及核酸检测方法 |
CN116297376B (zh) * | 2023-04-25 | 2023-08-29 | 中国科学院过程工程研究所 | 一种光电双模式生物探针及其应用 |
CN116574848A (zh) * | 2023-06-20 | 2023-08-11 | 中国农业科学院兰州兽医研究所 | 一种基于LAMP-CRISPRCas12a检测猪圆环2型病毒的引物及检测方法 |
CN116656784B (zh) * | 2023-07-26 | 2023-10-20 | 南京鸿明生物科技有限公司 | 一种免扩增的腺相关病毒基因组的滴度测量方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105441440A (zh) * | 2012-10-23 | 2016-03-30 | 基因工具股份有限公司 | 包含特异于靶dna的向导rna和cas蛋白质编码核酸或cas蛋白质的用于切割靶dna的组合物及其用途 |
WO2016123243A1 (en) * | 2015-01-28 | 2016-08-04 | The Regents Of The University Of California | Methods and compositions for labeling a single-stranded target nucleic acid |
WO2017070605A1 (en) * | 2015-10-22 | 2017-04-27 | The Broad Institute Inc. | Type vi-b crispr enzymes and systems |
CA2947904A1 (en) * | 2015-11-12 | 2017-05-12 | Pfizer Inc. | Tissue-specific genome engineering using crispr-cas9 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101935697B (zh) * | 2010-04-16 | 2015-11-25 | 中生方政生物技术有限公司 | 用于核酸序列检测的方法和试剂盒 |
RU2678001C2 (ru) * | 2012-12-13 | 2019-01-22 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Способы обнаружения днк для сайт-специфической нуклеазной активности |
US9790490B2 (en) * | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
ES2788176T3 (es) * | 2015-09-24 | 2020-10-20 | Sigma Aldrich Co Llc | Métodos y reactivos para la detección de proximidad molecular usando proteínas de unión a ácido nucleico guiadas por ARN |
CN107488710B (zh) * | 2017-07-14 | 2020-09-22 | 上海吐露港生物科技有限公司 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
US10253365B1 (en) * | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
-
2017
- 2017-07-14 CN CN201710573752.0A patent/CN107488710B/zh active Active
- 2017-07-14 CN CN202011092324.4A patent/CN112501254A/zh active Pending
-
2018
- 2018-04-12 KR KR1020207003220A patent/KR20200035956A/ko not_active Application Discontinuation
- 2018-04-12 BR BR112020000809-5A patent/BR112020000809A2/pt unknown
- 2018-04-12 SG SG11202000336RA patent/SG11202000336RA/en unknown
- 2018-04-12 CN CN202410308071.1A patent/CN118207297A/zh active Pending
- 2018-04-12 MA MA049579A patent/MA49579A/fr unknown
- 2018-04-12 WO PCT/CN2018/082769 patent/WO2019011022A1/zh unknown
- 2018-04-12 US US16/631,157 patent/US20230002811A1/en active Pending
- 2018-04-12 CN CN201880046701.5A patent/CN111094588B/zh active Active
- 2018-04-12 EP EP18832456.0A patent/EP3653722A4/en active Pending
- 2018-04-12 JP JP2020523474A patent/JP2020530779A/ja active Pending
- 2018-04-12 AU AU2018299445A patent/AU2018299445B2/en active Active
- 2018-04-12 CA CA3069788A patent/CA3069788A1/en active Pending
- 2018-04-12 NZ NZ760987A patent/NZ760987A/en unknown
- 2018-04-12 EA EA202090290A patent/EA202090290A1/ru unknown
- 2018-04-12 MX MX2020000481A patent/MX2020000481A/es unknown
-
2020
- 2020-01-13 IL IL272005A patent/IL272005A/en unknown
- 2020-01-14 PH PH12020500103A patent/PH12020500103A1/en unknown
- 2020-01-31 ZA ZA2020/00682A patent/ZA202000682B/en unknown
-
2022
- 2022-12-20 US US18/085,121 patent/US20230131421A1/en active Pending
-
2023
- 2023-04-13 JP JP2023065743A patent/JP2023080282A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105441440A (zh) * | 2012-10-23 | 2016-03-30 | 基因工具股份有限公司 | 包含特异于靶dna的向导rna和cas蛋白质编码核酸或cas蛋白质的用于切割靶dna的组合物及其用途 |
WO2016123243A1 (en) * | 2015-01-28 | 2016-08-04 | The Regents Of The University Of California | Methods and compositions for labeling a single-stranded target nucleic acid |
WO2017070605A1 (en) * | 2015-10-22 | 2017-04-27 | The Broad Institute Inc. | Type vi-b crispr enzymes and systems |
CA2947904A1 (en) * | 2015-11-12 | 2017-05-12 | Pfizer Inc. | Tissue-specific genome engineering using crispr-cas9 |
Non-Patent Citations (1)
Title |
---|
JONATHAN S. GOOTENBERG 等: "Nucleic acid detection with CRISPR-Cas13a/C2c2" * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110551800A (zh) * | 2018-06-03 | 2019-12-10 | 上海吐露港生物科技有限公司 | 一种耐高温Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN112236530A (zh) * | 2018-06-03 | 2021-01-15 | 上海吐露港生物科技有限公司 | 一种耐高温Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
CN111733216A (zh) * | 2020-06-22 | 2020-10-02 | 山东舜丰生物科技有限公司 | 一种提高目标核酸检测效率的方法 |
CN111733216B (zh) * | 2020-06-22 | 2023-03-28 | 山东舜丰生物科技有限公司 | 一种提高目标核酸检测效率的方法 |
CN112795624A (zh) * | 2020-07-17 | 2021-05-14 | 山东舜丰生物科技有限公司 | 利用含有无碱基间隔物的核酸检测器检测靶核酸的方法 |
CN112795624B (zh) * | 2020-07-17 | 2021-11-19 | 山东舜丰生物科技有限公司 | 利用含有无碱基间隔物的核酸检测器检测靶核酸的方法 |
WO2022012423A1 (zh) * | 2020-07-17 | 2022-01-20 | 山东舜丰生物科技有限公司 | 利用含有无碱基间隔物的核酸检测器检测靶核酸的方法 |
CN113293198B (zh) * | 2020-09-18 | 2022-12-02 | 山东舜丰生物科技有限公司 | 基于crispr技术进行靶核酸多重检测的方法 |
CN113293198A (zh) * | 2020-09-18 | 2021-08-24 | 山东舜丰生物科技有限公司 | 基于crispr技术进行靶核酸多重检测的方法 |
CN112301162A (zh) * | 2020-10-22 | 2021-02-02 | 清华-伯克利深圳学院筹备办公室 | 同时检测dna病毒和rna病毒的病毒核酸检测方法 |
CN112301162B (zh) * | 2020-10-22 | 2023-09-22 | 清华-伯克利深圳学院筹备办公室 | 同时检测dna病毒和rna病毒的病毒核酸检测方法 |
CN113061650A (zh) * | 2021-02-19 | 2021-07-02 | 中国科学院深圳先进技术研究院 | 一种病原体核酸的即时检测***及方法 |
CN113355397A (zh) * | 2021-06-24 | 2021-09-07 | 深圳市第二人民医院(深圳市转化医学研究院) | 场效应晶体管芯片、检测核酸的试剂盒和核酸含量的检测方法 |
WO2023087290A1 (en) * | 2021-11-20 | 2023-05-25 | Agricultural Genomics Institute At Shenzhen, Chinese Academy Of Agricultural Sciences | Methods for nucleic acid detection |
CN114807316A (zh) * | 2022-03-11 | 2022-07-29 | 北京科技大学 | 一种无核酸扩增可视化的rna定量检测方法 |
CN116179511A (zh) * | 2023-03-10 | 2023-05-30 | 之江实验室 | Cpf1蛋白在制备用于核酸检测的试剂盒中的应用 |
CN116179511B (zh) * | 2023-03-10 | 2023-12-22 | 之江实验室 | Cpf1蛋白在制备用于核酸检测的试剂盒中的应用 |
CN117821630A (zh) * | 2024-02-20 | 2024-04-05 | 江苏省家禽科学研究所 | 用于检测肠炎沙门氏菌的核酸检测试剂盒及方法 |
Also Published As
Publication number | Publication date |
---|---|
EP3653722A1 (en) | 2020-05-20 |
CN107488710A (zh) | 2017-12-19 |
IL272005A (en) | 2020-02-27 |
KR20200035956A (ko) | 2020-04-06 |
BR112020000809A2 (pt) | 2020-09-08 |
PH12020500103A1 (en) | 2020-10-19 |
US20230131421A1 (en) | 2023-04-27 |
MA49579A (fr) | 2020-05-20 |
WO2019011022A1 (zh) | 2019-01-17 |
JP2020530779A (ja) | 2020-10-29 |
JP2023080282A (ja) | 2023-06-08 |
EA202090290A1 (ru) | 2020-07-14 |
US20230002811A1 (en) | 2023-01-05 |
CN107488710B (zh) | 2020-09-22 |
CN112501254A (zh) | 2021-03-16 |
CN118207297A (zh) | 2024-06-18 |
CN111094588B (zh) | 2024-04-05 |
SG11202000336RA (en) | 2020-02-27 |
MX2020000481A (es) | 2020-09-10 |
AU2018299445B2 (en) | 2024-05-30 |
EP3653722A4 (en) | 2021-04-21 |
AU2018299445A1 (en) | 2020-02-06 |
NZ760987A (en) | 2024-03-22 |
CA3069788A1 (en) | 2019-01-17 |
ZA202000682B (en) | 2021-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111094588B (zh) | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 | |
CN110551800B (zh) | 一种耐高温Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 | |
CN110191961B (zh) | 制备经不对称标签化的测序文库的方法 | |
US20210269866A1 (en) | Crispr effector system based amplification methods, systems, and diagnostics | |
Kiddle et al. | GMO detection using a bioluminescent real time reporter (BART) of loop mediated isothermal amplification (LAMP) suitable for field use | |
JP2020530779A5 (zh) | ||
US11584955B2 (en) | Application of Cas protein, method for detecting target nucleic acid molecule and kit | |
KR20110106922A (ko) | 단일 세포 핵산 분석 | |
JP2021523704A (ja) | 方法 | |
CN114174535A (zh) | Crispr多靶标检测方法及其试剂盒 | |
EP3476938B1 (en) | Method and kit for synthesizing nucleic acid under constant temperature conditions | |
WO2006098428A1 (ja) | プライマーダイマーからの非特異的増幅を減少させる方法 | |
US20180320227A1 (en) | Method for quantifying target nucleic acid and kit therefor | |
JP2018183065A (ja) | Rna検出方法 | |
CN109852670A (zh) | 一种高特异性核酸检测试剂及其使用方法 | |
JP2008048648A (ja) | 核酸増幅用プライマーセット及び核酸の増幅方法 | |
CN115867653A (zh) | 用于检测靶核酸的环状引物和loop-de-loop方法 | |
JP2007319096A (ja) | エンドヌクレアーゼのニッキング活性を利用した核酸増幅法 | |
CN110551797B (zh) | 基于t5外切酶的双轮信号扩增目视检测层出镰刀菌的方法 | |
CN113337638A (zh) | 一种新型冠状病毒(SARS-CoV-2)的检测方法和试剂盒 | |
CN114182001B (zh) | 非对称环介导恒温条件下合成核酸的方法及试剂盒和应用 | |
EA042681B1 (ru) | Применение белка cas, способ для обнаружения целевой молекулы нуклеиновой кислоты и набор | |
US9212398B2 (en) | Cross priming amplification of target nucleic acids | |
JP2008161164A (ja) | 人工ミスマッチ核酸を含むプライマーを用いた遺伝子検出法 | |
WO2023178347A1 (en) | Methods and systems for pamless detection of nucleic acids with type v crispr/cas systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40029609 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant |